European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB)
NCT ID: NCT00797641
Last Updated: 2009-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2500 participants
OBSERVATIONAL
2009-01-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients admitted to the hospital, or inpatients admitted for another reason, presenting with overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia, as well as other clinical or laboratory evidence of acute blood loss from the upper gastrointestinal tract
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evidence that an upper GI endoscopy was performed
* The complete medical record is available for study related hospitalization.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ángel Lanas, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Clínico Universitario Lozano Blesa, Zaragoza (Spain)
Javier N Rivero, MSc
Role: STUDY_DIRECTOR
Medical Department, AstraZeneca Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research site
Aalst, , Belgium
Research site
Anderlecht, , Belgium
Research site
Assebroek, , Belgium
Research site
Braine-l'Alleud, , Belgium
Research site
Brasschaat, , Belgium
Research site
Bruges, , Belgium
Research site
Brussels, , Belgium
Research site
Charleroi, , Belgium
Research site
Deurne, , Belgium
Research site
Edegem, , Belgium
Research site
Geraardsbergen, , Belgium
Research site
Ghent, , Belgium
Research site
Hasselt, , Belgium
Research site
Herentals, , Belgium
Research site
Kortrijk, , Belgium
Research site
Lier, , Belgium
Research site
Liège, , Belgium
Research site
Mechelen, , Belgium
Research site
Ottignies Lln, , Belgium
Research site
Tielt, , Belgium
Research site
Tournai, , Belgium
Research site
Turnhout, , Belgium
Research site
Wetteren, , Belgium
Research site
Wilrijk, , Belgium
Research site
Zottegem, , Belgium
Research site
Athens, , Greece
Research site
Larissa, , Greece
Research site
Thessaloniki, , Greece
Research site
Bolzano, , Italy
Research site
Cosenza, , Italy
Research site
Crema, , Italy
Research site
Forlì, , Italy
Research site
Milan, , Italy
Research site
Napoli, , Italy
Research site
Novara, , Italy
Research site
Revenna, , Italy
Research site
Roma, , Italy
Research site
S. Giovanni Rotondo, , Italy
Research site
Siena, , Italy
Research site
Trieste, , Italy
Research site
Arendel, , Norway
Research site
Ålesund, , Norway
Research site
Bodø, , Norway
Research site
Drammen, , Norway
Research site
Fredrikstad, , Norway
Research site
Kristiansand, , Norway
Research site
Levanger, , Norway
Research site
Lillehammer, , Norway
Research site
Oslo, , Norway
Research site
Rud, , Norway
Research site
Stavanger, , Norway
Research site
Tromsø, , Norway
Research site
Trondheim, , Norway
Research site
Tønsberg, , Norway
Research site
Almada, , Portugal
Research site
Angra do Heroísmo, , Portugal
Research site
Braga, , Portugal
Research site
Caldas da Rainha, , Portugal
Research site
Castelo Branco, , Portugal
Research site
Covilha, , Portugal
Research site
Funchal, , Portugal
Research site
Leiria, , Portugal
Research site
Ponta Delgada, , Portugal
Research site
Santarém, , Portugal
Research site
Torres Novas, , Portugal
Research site
Alcázar de San Juan, , Spain
Research site
Alicante, , Spain
Research site
Barcelona, , Spain
Research site
Burgos, , Spain
Research site
Córdoba, , Spain
Research site
Huesca, , Spain
Research site
La Cuesta de Arguijon, , Spain
Research site
Las Palmas de Gran Canaria, , Spain
Research site
Logroño, , Spain
Research site
Madrid, , Spain
Research site
Marbella, , Spain
Research site
Murcia, , Spain
Research site
Ourense, , Spain
Research site
Oviedo, , Spain
Research site
Pamplona, , Spain
Research site
Sabadell, , Spain
Research site
Santiago de Compostela, , Spain
Research site
Seville, , Spain
Research site
Valencia, , Spain
Research site
Zaragoza, , Spain
Research site
Ankara, , Turkey (Türkiye)
Research site
Antalya, , Turkey (Türkiye)
Research site
Batman, , Turkey (Türkiye)
Research site
Bursa, , Turkey (Türkiye)
Research site
Diyarbakır, , Turkey (Türkiye)
Research site
Elâzığ, , Turkey (Türkiye)
Research site
Gaziantep, , Turkey (Türkiye)
Research site
Istanbul, , Turkey (Türkiye)
Research site
Izmir, , Turkey (Türkiye)
Research site
Konya, , Turkey (Türkiye)
Research site
Malatya, , Turkey (Türkiye)
Research site
Mersin, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lanas A, Aabakken L, Fonseca J, Mungan Z, Papatheodoridis G, Piessevaux H, Rotondano G, Nuevo J, Tafalla M. Variability in the management of nonvariceal upper gastrointestinal bleeding in Europe: an observational study. Adv Ther. 2012 Dec;29(12):1026-36. doi: 10.1007/s12325-012-0069-x. Epub 2012 Dec 6.
Mungan Z. An observational European study on clinical outcomes associated with current management strategies for non-variceal upper gastrointestinal bleeding (ENERGIB-Turkey). Turk J Gastroenterol. 2012;23(5):463-77. doi: 10.4318/tjg.2012.0402.
Lanas A, Aabakken L, Fonseca J, Mungan ZA, Papatheodoridis GV, Piessevaux H, Cipolletta L, Nuevo J, Tafalla M. Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe. Aliment Pharmacol Ther. 2011 Jun;33(11):1225-33. doi: 10.1111/j.1365-2036.2011.04651.x. Epub 2011 Apr 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GEU-DUM-2008/2
Identifier Type: -
Identifier Source: org_study_id